Maintaining market leadership in the Turkish pharmaceutical sector for 24 consecutive years, Abdi İbrahim has officially launched its commercial operations in North Macedonia. Unveiled at a corporate launch in Skopje, the 114-year-old pharmaceutical enterprise enters the market with a specialized portfolio focused across five core therapeutic areas: respiratory, central nervous system, cardiovascular, pain management, and consumer health (OTC).
Read More
